Trial Details
COMPLETEDBasic Information
| Clinical ID | c1482 |
|---|---|
| Identifier | NCT00790933 |
| Trial Title | An Open-label Study of Vedolizumab (MLN0002) in Participants With Ulcerative Colitis and Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Ulcerative Colitis|Crohn's Disease |
| Interventions | DRUG: Vedolizumab |
Participant Information
| Sponsor | Takeda |
|---|---|
| City | Birmingham |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2009-05-22 |
|---|---|
| Primary Completion Date | 2017-10-31 |
| Completion Date | 2017-10-31 |